[13C,2H2,15N]-Upadacitinib
| Catalog Number |
ACMA00065317 |
| Description |
Upadacitinib is intended for Pharmaceuticals applications and is a new member of the JAK (Janus kinase) inhibitor class, indicated for certain treatments of rheumatoid arthritis in adult patients. All information about [13C,2H2,15N]-Upadacitinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Molecular Weight |
384.37 |
| Molecular Formula |
C17H19F3N6O |
| Purity |
≥98% |
| Isotopic Enrichment |
99% 13C, 98% 2H, 98% 15N |
| Stability |
≥1 year |
| Unlabeled CAS |
1310726-60-3 |
Please kindly note that our products and services are for research use only.
